COASY Gene

COASY Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">COASY</th></tr>
<tr><td><strong>Full Name</strong></td><td>Coenzyme A Synthetase</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>COASY</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17q21.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>80317</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>609856</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000167468</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9P2R3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>CPAN (COASY Protein-Associated Neurodegeneration), NBIA, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

COASY (Coenzyme A Synthetase) encodes a bifunctional enzyme that plays a critical role in the coenzyme A (CoA) biosynthetic pathway. CoA is an essential cofactor for over 100 metabolic reactions, including fatty acid metabolism, the Krebs cycle, amino acid metabolism, steroid synthesis, and neurotransmitter synthesis. COASY mutations cause COASY Protein-Associated Neurodegeneration (CPAN), a rare form of neurodegeneration with brain iron accumulation (NBIA) characterized by progressive dystonia, spasticity, cognitive decline, and optic atrophy[@zhou2012][@dusi2014].

This page covers the gene's structure, protein function, expression patterns, disease associations, and relevance to neurodegenerative processes.

Gene and Protein Structure

COASY Gene

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#1976D2; color:white;">COASY</th></tr>
<tr><td><strong>Full Name</strong></td><td>Coenzyme A Synthetase</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>COASY</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>17q21.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>80317</td></tr>
<tr><td><strong>OMIM ID</strong></td><td>609856</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000167468</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>Q9P2R3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>CPAN (COASY Protein-Associated Neurodegeneration), NBIA, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

COASY (Coenzyme A Synthetase) encodes a bifunctional enzyme that plays a critical role in the coenzyme A (CoA) biosynthetic pathway. CoA is an essential cofactor for over 100 metabolic reactions, including fatty acid metabolism, the Krebs cycle, amino acid metabolism, steroid synthesis, and neurotransmitter synthesis. COASY mutations cause COASY Protein-Associated Neurodegeneration (CPAN), a rare form of neurodegeneration with brain iron accumulation (NBIA) characterized by progressive dystonia, spasticity, cognitive decline, and optic atrophy[@zhou2012][@dusi2014].

This page covers the gene's structure, protein function, expression patterns, disease associations, and relevance to neurodegenerative processes.

Gene and Protein Structure

Genomic Organization

The COASY gene (Gene ID: 80317) is located on chromosome 17q21.2 and spans approximately 30 kb of genomic DNA. The gene consists of 15 exons that encode a protein of 724 amino acids with a molecular weight of approximately 80 kDa.

Protein Architecture

The COASY protein possesses two catalytic domains that perform sequential reactions in CoA biosynthesis[@kneassel2009]:

The two-domain structure allows sequential processing of intermediates without releasing them, making COASY an efficient bifunctional enzyme.

Structure-Function Relationships

Key structural features of COASY include:

• ATP-binding motif: Required for both kinase and adenylyltransferase activities
• CoA-binding pocket: Mediates feedback inhibition by CoA
• Dimerization interface: Functional as a homodimer
• Mitochondrial targeting sequence: Directs protein to mitochondria where CoA synthesis occurs

Normal Physiological Function

Coenzyme A Biosynthesis

CoA biosynthesis proceeds through five enzymatic steps[@kneassel2009]:

Pantothenate → 4'-Phosphopantothenate → 4'-Phosphopantetheine →
Depospho-CoA → CoA

COASY performs the first and third steps:

Cellular Metabolism

CoA is essential for numerous metabolic pathways:

• Energy production: Central to Krebs cycle and oxidative phosphorylation
• Fatty acid metabolism: Activation of fatty acids for beta-oxidation
• Carbohydrate metabolism: Pyruvate dehydrogenase and other key enzymes
• Amino acid metabolism: Transamination and catabolism
• Neurotransmitter synthesis: Acetylcholine and GABA biosynthesis
• Steroid hormone synthesis: Cholesterol and steroid hormone production
• Protein modification: Post-translational fatty acylation (myristoylation, palmitoylation)

Tissue Distribution

COASY is ubiquitously expressed with high levels in:

• Brain: Particularly in the basal ganglia, hippocampus, and cortex
• Liver: High metabolic activity
• Kidney: Energy-intensive transport
• Heart muscle: Continuous energy demand
• Muscle: High fatty acid oxidation

Role in Neurodegenerative Diseases

COASY Protein-Associated Neurodegeneration (CPAN)

CPAN is a rare autosomal recessive disorder caused by biallelic COASY mutations[@zhou2012][@dusi2014][@iuso2019]:

Genetics

• Inheritance: Autosomal recessive
• Mutation types: Missense, nonsense, and splice-site mutations
• Prevalence: Very rare (<1 in 1,000,000)

Clinical Features

• Age of onset: Childhood to adolescence (typically 2-15 years)
• Progressive dystonia: Initial symptom in most patients
• Spasticity: Upper motor neuron signs
• Cognitive decline: Progressive intellectual disability
• Optic atrophy: Visual impairment
• Dysphagia: Swallowing difficulties
• Premature death: In severe cases

Neuropathology

• Iron accumulation: In the globus pallidus and substantia nigra
• Neuronal loss: In basal ganglia regions
• Axonal degeneration: White matter abnormalities
• Tau pathology: Some cases show tau aggregates

Diagnosis

• MRI: Shows iron deposition in basal ganglia
• Genetic testing: Confirmation of COASY mutations
• CoA levels: Reduced CoA in patient cells

Neurodegeneration with Brain Iron Accumulation (NBIA)

CPAN is classified within the NBIA spectrum[@ahmed2021][@gregor2021]:

| NBIA Type | Gene | Protein Function |
|-----------|------|-----------------|
| PKAN | PANK2 | Pantothenate kinase |
| PLAN | PLA2G6 | Phospholipase A2 |
| FA2H | FA2H | Fatty acid 2-hydroxylase |
| WDR45 | WDR45 | Autophagy protein |
| COASY | COASY | CoA synthetase |

The common mechanism is impaired CoA biosynthesis leading to mitochondrial dysfunction, oxidative stress, and iron dysregulation.

Alzheimer's Disease

COASY dysfunction may contribute to AD pathogenesis[@wang2022][@liu2023]:

• CoA levels: Reduced in AD brain
• Metabolic dysfunction: Impaired glucose metabolism
• Cholinergic deficit: Acetyl-CoA required for acetylcholine synthesis
• Mitochondrial dysfunction: Energy production impairment
• Oxidative stress: Increased ROS production
• Lipid metabolism: Altered membrane composition

Parkinson's Disease

COASY may play a role in PD:

• CoA in dopaminergic neurons: Essential for mitochondrial function
• Energy metabolism: PD involves mitochondrial complex I deficiency
• Oxidative stress: CoA-dependent antioxidant systems
• Iron dysregulation: Shared mechanism with NBIA
• Lipid metabolism: CoA required for myelin maintenance

Therapeutic Implications

Targeting CoA metabolism offers therapeutic opportunities[@liu2023][@leonardi2020]:

| Approach | Description | Development Stage |
|----------|-------------|-------------------|
| CoA supplementation | Provide CoA precursors | Research |
| Pantothenate (vit B5) | Bypass defective step | Case reports |
| Gene therapy | Deliver functional COASY | Preclinical |
| Small molecule stabilizers | Stabilize mutant protein | Preclinical |
| Antioxidants | Combat oxidative stress | Research |

Protein-Protein Interactions

COASY interacts with several proteins:

• PANK2: Sequential enzyme in CoA pathway
• PANK3: Alternative pantothenate kinase
• COX15: Mitochondrial function
• VDAC: Mitochondrial permeability
• CPT1/2: Fatty acid transport

Pathway Diagram

Animal Models

• Coasy knockout mice: Embryonic lethal (CoA essential)
• Conditional knockouts: Show metabolic defects
• Zebrafish models: Motor abnormalities
• Patient-derived iPSCs: Dopaminergic neurons show defects

Research Directions

Key research priorities include:

Key Publications

See Also

• [PANK2 Gene](/genes/pank2) - Related NBIA gene (pantothenate kinase)
• [Neurodegeneration with Brain Iron Accumulation](/diseases/nbia-overview) - NBIA overview
• [Pantothenate Kinase-Associated Neurodegeneration](/diseases/pantothenate-kinase-associated-neurodegeneration-pkan) - PKAN disease
• [Coenzyme A Biosynthesis Pathway](/mechanisms/coa-biosynthesis) - CoA pathway
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) - Mitochondrial mechanisms

External Links

• [NCBI Gene: COASY](https://www.ncbi.nlm.nih.gov/gene/80317)
• [UniProt: Q9P2R3](https://www.uniprot.org/uniprot/Q9P2R3)
• [Ensembl: ENSG00000167468](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167468)
• [OMIM: 609856](https://www.omim.org/entry/609856)
• [GeneCards: COASY](https://www.genecards.org/cgi-bin/carddisp.pl?gene=COASY)